UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial: Decoding checkpoint inhibitor-induced endocrinopathies

Frontiers in endocrinology (Lausanne), 2022-07, Vol.13, p.987648-987648

2022

Volltextzugriff (PDF)

Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II

Frontiers in endocrinology (Lausanne), 2023-10, Vol.14, p.1317220-1317220

2023

Volltextzugriff (PDF)

EGFR–Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors

Journal of thoracic oncology, 2017-03, Vol.12 (3), p.585-590

2017

Volltextzugriff (PDF)

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy

Frontiers in oncology, 2022-07, Vol.12, p.894015-894015

2022

Volltextzugriff (PDF)

Understanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes

BioEssays, 2018-08, Vol.40 (8), p.e1800050-n/a

2018

Volltextzugriff (PDF)

Oligometastatic colorectal adenocarcinoma to the spleen and ovaries

Journal of surgical case reports, 2024-04, Vol.2024 (4), p.rjae241

2024

Volltextzugriff (PDF)

Pseudoprogression Associated with Clinical Deterioration and Worsening Quality of Life in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2018-01, Vol.13 (1), p.e1-e2

2018

Volltextzugriff (PDF)

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms

Journal of clinical medicine, 2018-06, Vol.7 (6), p.151

2018

Volltextzugriff (PDF)

"Standard Care" in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trials

Journal of the National Comprehensive Cancer Network, 2017-09, Vol.15 (9), p.1131-1139

2017

Volltextzugriff (PDF)

Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancer

Immunotherapy, 2019-06, Vol.11 (8), p.657-665

2019

Volltextzugriff (PDF)

Prolonged Disease Control on Nivolumab for Primary Pulmonary NUT Carcinoma

Clinical lung cancer, 2021-09, Vol.22 (5), p.e665-e667

2021

Volltextzugriff (PDF)

What do consumers see as important in the continuity of their care?

Supportive care in cancer, 2013-09, Vol.21 (9), p.2637-2642

2013

Volltextzugriff (PDF)

Psychological impact of exceptional response in people with advanced cancer: a qualitative exploration

Journal of cancer survivorship, 2024-08

2024

Volltextzugriff (PDF)

Blood and guts: peripheral immune correlates of immunotherapy‐induced colitis

Immunology and cell biology, 2023-01, Vol.101 (1), p.12-15

2023

Volltextzugriff (PDF)

Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors

Lung cancer (Amsterdam, Netherlands), 2021-05, Vol.155, p.28-33

2021

Volltextzugriff (PDF)

Association of common inherited NOD2 mutations with exceptional response to immune checkpoint inhibitors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2514-2514

2023

Volltextzugriff (PDF)

369. GENOMIC ALTERATIONS AND SURVIVAL AFTER TREATMENT OF EAC BY SURGERY WITHOUT CHEMO- OR RADIOTHERAPY

Diseases of the esophagus, 2022-09, Vol.35 (Supplement_2)

2022

Volltextzugriff (PDF)

Association between efficacy of immunotherapy and rate of cancer progression at the time of initiation of immunotherapy: An analysis in metastatic non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21225-e21225

2018

Volltextzugriff (PDF)

P3.02c-055 Incidence and Grade of Pneumonitis in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Anti-PD-1 Antibodies: Topic: IT

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1308-S1308

2017

Volltextzugriff (PDF)

P3.02c-055 Incidence and Grade of Pneumonitis in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Anti-PD-1 Antibodies

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1308

2017

Volltextzugriff (PDF)

Abstract 665: Correlation between a CTLA-4 single nucleotide polymorphism and high response to anti-PD1/PDL1 immunotherapy in advanced non small cell lung cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.665-665

2022

Volltextzugriff (PDF)

Abstract LB-121: Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-121-LB-121

2018

Volltextzugriff (PDF)

Oligometastatic colorectal adenocarcinoma to the spleen and ovaries

Journal of surgical case reports, 2024, Vol.2024 (4), p.rjae241-rjae241

2024

Volltextzugriff (PDF)

Physician Engagement Strategies in Care Coordination: Findings from the Centers for Medicare & Medicaid Services’ Health Care Innovation Awards Program

Health services research, 2017-02, Vol.52 (1), p.291-312

2017

Volltextzugriff (PDF)

A Framework for Rigorous Qualitative Research as a Component of Mixed Method Rapid-Cycle Evaluation

Qualitative health research, 2019-01, Vol.29 (2), p.279-289

2019

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)
Berichte
(1)
Reviews
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Humans
(11)
Female
(7)
Oncology
(7)
Immunotherapy
(6)
Male
(5)
Aged
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Lung Neoplasms - Drug Therapy
(4)
Cancer
(3)
Carcinoma, Non-Small-Cell Lung - Genetics
(3)
Health Care
(3)
Immunology
(3)
Lung Neoplasms - Genetics
(3)
Middle Aged
(3)
Mutation
(3)
Patients
(3)
Retrospective Studies
(3)
Adult
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editorial: Decoding checkpoint inhibitor-induced endocrinopathies

Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II

EGFR–Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy

Understanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes

Oligometastatic colorectal adenocarcinoma to the spleen and ovaries

Pseudoprogression Associated with Clinical Deterioration and Worsening Quality of Life in Malignant Pleural Mesothelioma

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms

"Standard Care" in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trials

Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancer

Prolonged Disease Control on Nivolumab for Primary Pulmonary NUT Carcinoma

What do consumers see as important in the continuity of their care?

Psychological impact of exceptional response in people with advanced cancer: a qualitative exploration

Blood and guts: peripheral immune correlates of immunotherapy‐induced colitis

Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors

Association of common inherited NOD2 mutations with exceptional response to immune checkpoint inhibitors

369. GENOMIC ALTERATIONS AND SURVIVAL AFTER TREATMENT OF EAC BY SURGERY WITHOUT CHEMO- OR RADIOTHERAPY

Association between efficacy of immunotherapy and rate of cancer progression at the time of initiation of immunotherapy: An analysis in metastatic non-small cell lung cancer (NSCLC)

P3.02c-055 Incidence and Grade of Pneumonitis in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Anti-PD-1 Antibodies: Topic: IT

P3.02c-055 Incidence and Grade of Pneumonitis in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Anti-PD-1 Antibodies

Abstract 665: Correlation between a CTLA-4 single nucleotide polymorphism and high response to anti-PD1/PDL1 immunotherapy in advanced non small cell lung cancer

Abstract LB-121: Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing

Oligometastatic colorectal adenocarcinoma to the spleen and ovaries

Physician Engagement Strategies in Care Coordination: Findings from the Centers for Medicare & Medicaid Services’ Health Care Innovation Awards Program

A Framework for Rigorous Qualitative Research as a Component of Mixed Method Rapid-Cycle Evaluation

Suchergebnisse filtern